Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /HealthTech

HealthTech

54 VCs and 5 funds investing in HealthTech

VCs investing in HealthTech

Olivier Dubuisson

Managing Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Olivier Dubuisson as Managing Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Catherine Boule

Managing Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Catherine Boule as Managing Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Yvan-Michel Ehkirch

Managing Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Yvan-Michel Ehkirch as Managing Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Baudouin Hue

Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Baudouin Hue as Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Benjamin Zerbib

Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Benjamin Zerbib as Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Agathe Biard

Chief Compliance Officer

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Agathe Biard as Chief Compliance Officer. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

SeedSeries ASeries B

Emmanuel Daugeras

Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Emmanuel Daugeras as Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Tom Beauvironnet

Investment Manager

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Tom Beauvironnet as Investment Manager. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Alexandra Desproges

Office Manager

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Alexandra Desproges as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

SeedSeries ASeries B

Amine Benmoussa

Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Amine Benmoussa as Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Alain Gavin

Venture Partner

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Alain Gavin as Venture Partner. This profile applies Karista's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead or co-lead early rounds for European technology and healthcare companies, working closely with founders from inception through scaling.

SeedSeries ASeries B

Anna Casal

Head of Communication

80%

Karista

Check: Karista does not publish a single standard current check-size range across its funds.

The official roster identifies Anna Casal as Head of Communication. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

SeedSeries ASeries B

Artur Banach

Partner

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Artur Banach as Partner. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Łukasz Pawłowski

Partner

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Łukasz Pawłowski as Partner. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Radosław Rejman

Partner

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Radosław Rejman as Partner. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Przemysław Jurgiel-Żyła

Investment Director

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Przemysław Jurgiel-Żyła as Investment Director. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Michał Olszewski

Partner

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Michał Olszewski as Partner. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Maciej Kraus

Partner

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Maciej Kraus as Partner. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Zofia Sidorska

Operations Manager

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Zofia Sidorska as Operations Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Pre-SeedSeedSeries A

Bartosz Składzień

Investment Director

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Bartosz Składzień as Investment Director. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Łukasz Lewandowski

Investment Director

80%

Movens Capital

Check: €250K-€3M published initial range, with follow-ons up to €5M.

The official roster identifies Łukasz Lewandowski as Investment Director. This profile applies Movens Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Support defensible CEE technology businesses with strong technical teams, global market potential and a credible path to €50M-plus annual recurring revenue.

Pre-SeedSeedSeries A

Przemysław Dyderski

Finance Manager

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Przemysław Dyderski as Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Pre-SeedSeedFollow-On

Marcin Kurek

Partner

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Marcin Kurek as Partner. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Anastasia Lisowska

Office Manager

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Anastasia Lisowska as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Pre-SeedSeedFollow-On

Jacek Łubiński

Partner

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Jacek Łubiński as Partner. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Michał Mroczkowski

Partner

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Michał Mroczkowski as Partner. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Jakub Ślusarczyk

Partner

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Jakub Ślusarczyk as Partner. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Kamil Węgliński

Investment Manager

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Kamil Węgliński as Investment Manager. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Marcin Zabielski

Partner

80%

Market One Capital

Check: Market One Capital does not publish a standard current check-size range on its official site.

The official roster identifies Marcin Zabielski as Partner. This profile applies Market One Capital's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Back European founders building platforms and marketplaces that change market logic, exploit uncommon inefficiencies and compound through network effects.

Pre-SeedSeedFollow-On

Lucanus Polagnoli

Founding Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Lucanus Polagnoli as Founding Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Stephanie Urbanski

Managing Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Stephanie Urbanski as Managing Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Johannes Blaschke

Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Johannes Blaschke as Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Ekaterina Gianelli

Venture Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Ekaterina Gianelli as Venture Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Paul Varga

Venture Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Paul Varga as Venture Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Philippa Allen

Investment Manager

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Philippa Allen as Investment Manager. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Michela Grimaldi

Communications Manager

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Michela Grimaldi as Communications Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Pre-SeedSeed

Nina Kasmaei-Gatzmaga

Founders Associate

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Nina Kasmaei-Gatzmaga as Founders Associate. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Julinka Waesche

Visiting Analyst

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Julinka Waesche as Visiting Analyst. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Matteo Vannucchi

Visiting Analyst

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Matteo Vannucchi as Visiting Analyst. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Matheus Verweijen

Junior Finance Manager

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Matheus Verweijen as Junior Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Pre-SeedSeed

Tim Schneider

Supporting Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Tim Schneider as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Haymo Meran

Supporting Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Haymo Meran as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Ita Ekpoudom

Supporting Partner

80%

Calm/Storm Ventures

Check: Calm/Storm does not publish a standard current startup check-size range on its official site.

The official roster identifies Ita Ekpoudom as Supporting Partner. This profile applies Calm/Storm Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Partner very early with diverse European founders redefining health and wellbeing, combining specialist industry support with a founder community.

Pre-SeedSeed

Eckhardt Weber

Founding Managing Partner

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Eckhardt Weber.

Eckhardt Weber works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Christian Lautner

Founding Managing Partner

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Christian Lautner.

Christian Lautner works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Marta Mrozowicz

Investment Team

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Marta Mrozowicz.

Marta Mrozowicz works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Cecilia von Oldershausen

Finance and Operations

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Cecilia von Oldershausen.

Cecilia von Oldershausen serves Heal Capital as Finance and Operations. The official sources do not publish a separate personal investment thesis, so the profile retains the firm's stated strategy without attributing it personally.

Early StageGrowth Stage

Dr. Lucas Mittelmeier

Investment Team

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Lucas Mittelmeier.

Dr. Lucas Mittelmeier works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Dr. Vahid Asimi

Investment Team

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Vahid Asimi.

Dr. Vahid Asimi works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Felix Nizet

Investment Team

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Felix Nizet.

Felix Nizet works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Dr. Markus Müschenich

Founding Partner

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Markus Müschenich.

Dr. Markus Müschenich works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Peter Wibbe

Venture Partner

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Peter Wibbe.

Peter Wibbe works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Dr. Christian Weiss

Venture Partner

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Dr. Christian Weiss.

Dr. Christian Weiss works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Arda Uckan

Engineering Fellow

80%

Heal Capital

Check: Heal Capital does not publish a standard current check-size range on its official site.. No person-specific check range is inferred for Arda Uckan.

Arda Uckan works on Heal Capital's strategy to back mission-driven European HealthTech founders with capital and access to healthcare-system expertise to improve care and patient outcomes. The firm does not publish a narrower personal mandate on the cited roster.

Early StageGrowth Stage

Funds focused on HealthTech

Calm/Storm Ventures

Vienna, Austria

14 people0 investments

Karista

Paris, France

12 people0 investments

Heal Capital

Berlin, Germany

11 people0 investments

Movens Capital

Warsaw, Poland

9 people0 investments

Market One Capital

Luxembourg / Warsaw, Poland

8 people0 investments